Home > Boards > US Listed > Biotechs >

CORVUS PHARMACEUTICALS (CRVS)

CRVS RSS Feed
Add CRVS Price Alert      Hide Sticky   Hide Intro
Moderator: area wireless rep
Search This Board: 
Last Post: 7/30/2020 11:18:38 PM - Followers: 11 - Board type: Free - Posts Today: 0




https://www.corvuspharma.com/

https://www.phillyvoice.com/temple-covid19-immunotherapy-clinical-trial-corvus-coronavirus-research/

https://clinicaltrials.gov/ct2/show/NCT04464395?type=Intr&cond=COVID-19&sort=nwst&draw=2
 

July 7, 2020 09:36 AM ET (BZ Newswire) -- News

Shares of Corvus Pharmaceuticals Inc (NASDAQ:CRVS) are "" rel="nofollow ugc" target="_blank">https://www.benzinga.com/pre-market-outlook/20/07/16530313/18-healthcare-stocks-moving-in-tuesdays-pre-market-session"; rel="nofollow ugc">advancing strongly Tuesday following an announcement concerning its foray into COVID-19 treatment.

What Happened: The Burlingame, California-based company said the FDA has reviewed and accepted its investigational new drug application for initiating a COVID-19 study. Accordingly, the company said it has initiated a Phase 1 study to investigate a novel immunotherapy approach for patients with COVID-19.

The company said it's studying an agonistic humanized monoclonal antibody, designated as CPI-006, which has demonstrated a potential new approach to immunotherapy of infectious diseases and cancer.

CPI-006, according to the company, has demonstrated binding to various immune cells and the inducement of a humoral adaptive immune response – B cell activation and lymphocyte trafficking leading to the production of antigen-specific immunoglobulin antibodies.

It has also led to increased levels of memory B cells, which are the cells responsible for long-term immunity, it added.

The company said these may provide immediate and long-term clinical benefits, including shortened recovery time and improved long-term protective immunity, for patients infected by SARS-CoV-2, the virus that causes COVID-19.

What's Next: Corvus expects to enroll up to 30 COVID-19 patients with mild to moderate symptoms in the Phase 1 study, with the patients receiving a single dose of CPI-006, with levels of 0.3, 1, 3 and 5 mg/kg, escalating in four cohorts as the study progresses.

The primary efficacy endpoint is the change in serum immunoglobulin anti-SARS-CoV-2 levels compared to baseline at day 28.
The study also will examine the safety and other clinical endpoints, including time to resolution of symptoms and duration of hospitalization.

The company expects to report data from the study later this year.

If the study meets its objectives, Corvus said it intends to work with the FDA to initiate a broader, randomized study at a fixed dose of CPI-006 that could potentially be adapted into a pivotal study to support a regulatory submission for FDA approval.

Shares were rallying 85.04% to $5.07

 


 
CRVS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CRVS News: Corvus Pharmaceuticals to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference 08/04/2020 04:05:10 PM
CRVS News: Quarterly Report (10-q) 07/30/2020 06:47:35 PM
CRVS News: Current Report Filing (8-k) 07/30/2020 06:42:13 PM
CRVS News: Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results 07/30/2020 04:02:10 PM
CRVS News: Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2020 Financial Results on July 30, 2020 07/23/2020 08:30:10 AM
PostSubject
#69   Take it. sorry u need it. Haha. not Pennsy 07/30/20 11:18:38 PM
#68   One couldn't move this stock with a plow. Pennsy 07/30/20 02:10:33 PM
#67   Someone either feed this dog or shoot it, Pennsy 07/30/20 11:42:49 AM
#66   I guess an up day is way too Pennsy 07/28/20 04:13:08 PM
#65   You guys good if i sell and leave? Ty Pennsy 07/28/20 03:28:39 PM
#64   Interesting tactic to erode away share price the Pennsy 07/27/20 05:27:33 PM
#63   Looking forward to Thursday. Perhaps if the market Pennsy 07/26/20 06:30:55 PM
#62   Welcome to the board. Pretty tight-lipped around here. Pennsy 07/23/20 08:17:14 PM
#61   I’m a new investor in Corvus. I like Tecmo Bowl 07/23/20 03:12:18 PM
#60   Perhaps after their reporting on 7/30, one may Pennsy 07/23/20 01:31:38 PM
#59   I didn't anticipate this is a tortuous race! Pennsy 07/20/20 07:14:35 PM
#58   Wtf! This stupid ticker can't even get out Pennsy 07/20/20 09:48:04 AM
#57   Looking forward to see if this can get Pennsy 07/19/20 05:28:28 PM
#56   Starting to think this board is merely a Pennsy 07/17/20 09:39:29 AM
#55   Seems like awr, is MIA. Probably best to Pennsy 07/16/20 08:21:24 AM
#54   Perhaps the speculation is only pertinent when things Pennsy 07/15/20 02:34:33 PM
#53   Take it away in dollars and give it Pennsy 07/15/20 12:56:28 PM
#52   The little train that could? Pennsy 07/15/20 10:19:27 AM
#51   Hey! I didn't lose too much today! I Pennsy 07/14/20 04:08:45 PM
#50   Perhaps the CEO, will write a book on Pennsy 07/14/20 08:25:50 AM
#49   Well, it would appear the board has now Pennsy 07/14/20 08:08:42 AM
#48   It would appear some Shenanigans are going on Pennsy 07/13/20 04:36:28 PM
#47   Closed at $3.91. So close. Only missed that Dennisb68 07/13/20 04:07:42 PM
#46   Haha. Guessing I should average down. Lol. Well, Pennsy 07/13/20 03:36:47 PM
#45   Down 9% so far today. Not good.. Dennisb68 07/13/20 01:44:45 PM
#44   Well, you like me did not think that. Pennsy 07/13/20 01:38:36 PM
#43   Yes, especially for a stock that was predicted Dennisb68 07/13/20 01:07:30 PM
#42   Down 29 cents. Dennisb68 07/13/20 10:48:52 AM
#41   One hell of a correction right now! Wow! Pennsy 07/13/20 10:28:15 AM
#40   So far the stock is up 4 cents Dennisb68 07/13/20 09:52:44 AM
#39   Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 area wireless rep 07/11/20 07:03:44 PM
#38   Wow! Thanks for sharing. Didn't realize that CRVS Pennsy 07/11/20 02:31:47 PM
#37   The technicals say this is over 9 dollars area wireless rep 07/11/20 01:07:09 PM
#36   Right on! I hope your enthusiasm translates to Pennsy 07/11/20 01:03:53 PM
#35   https://i.ibb.co/ykGfCc6/fffff.png HAMMERTIME CONFIRMED$$$$$$$$$$$$$$$$$$$$$ area wireless rep 07/11/20 08:15:21 AM
#34   Hammer at the bottom.This thing is going to bust area wireless rep 07/11/20 08:11:42 AM
#33   https://i.ibb.co/5FCH694/2020-tt07-11-FLEXIBLE-GRID.png The 4.40 p area wireless rep 07/11/20 07:48:57 AM
#32   [url=https://ibb.co/nrLVSHh]https://i.ibb.co/mJcY7LQ/2020-07-11-FLss-EXIBLE area wireless rep 07/11/20 07:45:07 AM
#31   [url=https://ibb.co/VYL5hmS]https://i.ibb.co/chyVpLF/2020-07-11-FLEXIBLE-GR area wireless rep 07/11/20 07:43:14 AM
#30   Amazing dd we’re hitting 10+ imo Monday area wireless rep 07/11/20 07:08:24 AM
#29   https://www.phillyvoice.com/temple-covid19-immunotherapy-clinical-trial-corvus-c Dina 07/11/20 07:05:45 AM
#28   Bullflag pattern confirmed$$$$$$$ area wireless rep 07/11/20 05:58:29 AM
#27   9dollars Monday area wireless rep 07/11/20 05:16:20 AM
#26   https://www.tradingview.com/x/yiBWTkAy/ area wireless rep 07/11/20 02:29:17 AM
#25   I don’t think so looking at the 5 area wireless rep 07/11/20 02:03:41 AM
#24   I hope this dog didn't die, it definitely Pennsy 07/10/20 06:50:46 PM
#23   Lol ipo_dude 07/08/20 01:01:07 AM
#22   Emma: Recently the NCI launched a study that area wireless rep 07/07/20 06:30:53 PM
#21   * * $CRVS Video Chart 07-07-2020 * * ClayTrader 07/07/20 04:38:48 PM
#20   CRVS nice pop on CV-scam capitalization ~ $treet $inatra 07/07/20 12:43:53 PM
PostSubject